Onboarding: Nearly Half a Year to Under Two Months. Literature Reviews: Over 70% Faster.
A Series B biotech startup with 60 employees in Rockville, MD developing therapeutics in a competitive space.
A Series B biotech startup with 60 employees in Rockville, MD developing therapeutics in a competitive space.
What They Were Facing
A Series B biotech startup with 60 employees in Rockville, MD was hitting a knowledge management wall that threatened to slow their pipeline progress. The company was developing therapeutics in a competitive space, and keeping up with the scientific literature was a full-time job for multiple people. Two to three FTEs were dedicated almost entirely to monitoring published research, FDA regulatory updates, and competitive intelligence, scanning hundreds of papers and filings per week for anything relevant to the company's programs. Standard operating procedures were scattered across Google Drive folders, a legacy wiki that nobody updated, and the personal notes of senior scientists. When a new researcher joined (and the company was hiring aggressively post-Series B), it took four to six months before they were fully productive. They'd spend their first weeks asking the same questions that every new hire asked, and the answers lived in different people's heads. The regulatory monitoring gap was the most dangerous problem. In biotech, missing an FDA guidance update or a competitor's clinical trial result can mean months of wasted effort. The team had experienced exactly this scenario six months before engaging us: a regulatory pathway change that should have triggered a protocol adjustment wasn't caught for three weeks because the analyst responsible was focused on a different program. The delay cost them a quarter's worth of timeline. Leadership wanted a system that could serve as the company's collective memory, something that knew where every document was, stayed current on the external literature, and could answer a scientist's question in 30 seconds instead of 30 minutes.
Two to three FTEs dedicated to monitoring published research, FDA updates, and competitive intelligence
SOPs scattered across Google Drive, legacy wiki, and personal notes of senior scientists
New researcher onboarding taking four to six months to reach full productivity
Missed FDA guidance update cost a quarter's worth of timeline six months prior
No centralized system serving as the company's collective memory
How We Solved It
We spent the first two weeks cataloguing the company's entire knowledge landscape: 6,400 internal documents across Google Drive, Confluence, the legacy wiki, and email archives. We also mapped the external sources that the monitoring team tracked manually, including specific PubMed search queries, FDA guidance pages, ClinicalTrials.gov registrations for competitor programs, and key journal RSS feeds. The core system is a RAG-powered knowledge assistant that indexes all internal documents and makes them queryable through natural language. A scientist can ask "What was the rationale for the dose escalation protocol in Program X?" and get an answer with citations to the specific SOP, the meeting notes where the decision was made, and the published literature that informed it. The system surfaces the context, not just the document link. For external monitoring, we built automated ingestion pipelines that pull from PubMed, FDA.gov, and ClinicalTrials.gov on a configurable schedule. New publications and filings are processed, summarized, and checked against the company's interest areas. Relevant items are flagged and routed to the appropriate program team. Every Friday, the system generates a weekly digest that summarizes everything new in each program's domain, complete with plain-language summaries and links to the source material. We also built an SOP management layer. When a standard operating procedure is updated, the system detects the change, indexes the new version, and notifies affected teams. When a scientist queries the system, they always get the current version. The legacy wiki's content was migrated into the knowledge base and retired. The system runs within the company's existing cloud infrastructure with access controls that mirror their organizational permissions. Lab notebooks and pre-publication data are restricted to authorized users. Everything is logged for regulatory audit purposes.
Catalogued 6,400 internal documents across Google Drive, Confluence, legacy wiki, and email archives
RAG-powered knowledge assistant with natural language queries returning answers with source citations
Automated ingestion pipelines pulling from PubMed, FDA.gov, and ClinicalTrials.gov on configurable schedules
Weekly digest system summarizing new publications and filings per program domain
SOP management layer detecting changes, indexing new versions, and notifying affected teams
Measurable Outcomes
Quantifiable improvements delivered within the project timeline
Reduced from nearly half a year to under two months average for new researchers
Literature review time reduced by over 70% across the research team
Zero missed FDA or regulatory updates since deployment
Research staff reading the weekly digest regularly
All procedures indexed, searchable, and version-controlled
Questions per day from a 60-person team
The onboarding improvement was the metric the CEO cared about most. With the company planning to grow significantly over the next year, shaving months off ramp-up time per hire translates to significant productive capacity. For a biotech burning through Series B funding, time-to-productivity directly affects runway. The literature monitoring improvement also had strategic value beyond time savings. During the first three months post-deployment, the system flagged a competitor's Phase II trial design change that the monitoring team confirmed they would have caught eventually, but probably not for two to three weeks. Having it surfaced within 24 hours gave the company's clinical strategy team time to adjust their own protocol design before the next FDA interaction.
Implementation Timeline
A structured approach from discovery to deployment
Inventoried 6,400 documents and mapped external monitoring sources
Weeks 1-2Inventoried 6,400 documents and mapped external monitoring sources
Internal document indexing and natural language search
Weeks 3-5Internal document indexing and natural language search
PubMed, FDA, and ClinicalTrials.gov automated ingestion
Weeks 6-7PubMed, FDA, and ClinicalTrials.gov automated ingestion
Automated digest generation and version-controlled SOP layer
Week 8Automated digest generation and version-controlled SOP layer
Permission implementation, staff training, and validation
Weeks 9-10Permission implementation, staff training, and validation
Controlled rollout for feedback collection
Week 11Controlled rollout for feedback collection
Organization-wide access with monitoring
Week 12Organization-wide access with monitoring
Frequently Asked Questions
How does the system handle proprietary research data and pre-publication findings?
Access controls are enforced at the document level, matching the company's existing permission structure. Pre-publication data, lab notebooks, and restricted program materials are only accessible to authorized users. The system logs every query and retrieval for regulatory audit trail purposes. During our build, we worked with the company's IP counsel to ensure the architecture met their data governance requirements.
Can the system distinguish between high-quality and low-quality published research?
The system doesn't make subjective quality judgments, but it provides context that helps researchers assess relevance quickly. Each surfaced paper includes the journal's impact factor, citation count (for older papers), study design type, and sample size where available. Researchers told us this metadata saved them from opening papers they would have immediately discarded.
What happens when external sources change their APIs or data formats?
We built the ingestion layer with adapter patterns so each external source has its own connector. When PubMed or FDA.gov changes their API (which happens), only the affected connector needs updating rather than the entire pipeline. We also built health checks that alert the admin team if any source stops returning expected data, so failures are caught within hours rather than discovered weeks later when someone notices the digest is missing a source.
How does this compare to commercial biotech knowledge management platforms?
Commercial platforms in this space typically charge six figures annually and require 6-12 months of implementation. They're also generic by design. Our system was built specifically around this company's programs, therapeutic areas, and workflows. The tradeoff is that a custom build requires more upfront investment in configuration, but the result is a system that fits the team's actual work patterns rather than forcing them to adapt to a vendor's assumptions.
Services Used in This Project
Ready for Similar Results?
Schedule a discovery call to discuss your specific challenges and learn how we can deliver measurable outcomes for your organization.
Schedule Discovery Call